GC
ANAC

Globeflex Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Globeflex Capital’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,800
Closed -$994K – 547
2015
Q4 		$994K Hold
8,800
– – 0.26% 144
2015
Q3 		$1.04M Sell
8,800
-1,300
-13% -$170K 0.22% 153
2015
Q2 		$782K Buy
+10,100
New +$662K 0.14% 267

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Globeflex Capital's ANAC Position: Q1 2016 in Review

Globeflex Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 8,800 shares — an estimated $994K sold.

Globeflex Capital first reported a position in ANAC in Q2 2015 and held it in 3 quarters. The position peaked at $1.04M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Globeflex Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Globeflex Capital sold 8,800 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $994K.
  • Globeflex Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 3 quarters.
  • Globeflex Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $1.04M in Q3 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Globeflex Capital's 13F filing for Q1 2016, filed 3 May 2016.